January 30, 2015 — ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology ...
Balloon Catheter
This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.
January 28, 2015 — Maquet Medical Systems USA announced an agreement to serve as the exclusive U.S. distributor of ...
January 28, 2015
January 13, 2015 — Shockwave Medical announced CE Mark regulatory approval for the company’s Lithoplasty balloon ...
January 13, 2015Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023January 9, 2015 — Covidien announced it has received CE Mark approval for its Stellarex drug-coated angioplasty balloon ...
January 09, 2015
January 5, 2015 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated ...
January 05, 2015
December 29, 2014 — The results of a study published online and in Circulation indicate that a medical device from ...
December 29, 2014
December 26, 2014 — The results of a landmark study published this month in Circulation indicate that a device from ...
December 26, 2014
December 19, 2014 — Cardionovum GmbH announced that it has initiated a 150-patient clinical study of its novel paclitaxe ...
December 19, 2014
December 4, 2014 — Covidien announced that it received U.S. Food and Drug Administration 510(k) clearance for its Fortre ...
December 04, 2014Nov. 14, 2014 — Covidien releases 12-month results of the DEFINITIVE AR study, the first randomized study designed to ...
November 14, 2014Nov. 13, 2014 — Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations ...
November 13, 2014
Nov. 12, 2014 — Catalist-listed QT Vascular Ltd. has acquired a novel technology platform called Java, and all ...
November 12, 2014
Nov. 11, 2014 — Shockwave Medical announced positive clinical results from Disrupt PAD trial, a single-arm multicenter ...
November 11, 2014Nov. 10, 2014 — For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug ...
November 10, 2014November 4, 2014 — Shockwave Medical announced that the company will present clinical results from DISRUPT PAD, a single ...
November 04, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now